Aurora Cannabis' $80 Million Mistake

Every company makes its fair share of mistakes. Aurora Cannabis (NYSE: ACB) is no exception.

Just over the last 12 months, the Canadian cannabis producer has reported several abysmal quarterly results (although with a pleasantly positive surprise in its most recent quarter). It temporarily lost the right to market medical cannabis in the important German market because of failure to obtain proper licensing. And last week, Aurora revealed its latest error.

The company didn't broadcast that it had made a bad move, mind you. But the big blunder was readily evident nonetheless. Here's what you need to know about Aurora's latest $80 million mistake.

Continue reading

Source Fool.com